Holen Sie sich die Stockscreener-App
4.46
1.13%
0.05
Handel nachbörslich:
4.50
0.04
+0.90%
Schlusskurs vom Vortag:
$4.41
Offen:
$4.41
24-Stunden-Volumen:
97,363
Relative Volume:
0.15
Marktkapitalisierung:
$47.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-5.5294
EPS:
-0.8066
Netto-Cashflow:
-
1W Leistung:
-1.11%
1M Leistung:
+67.04%
6M Leistung:
+72.87%
1J Leistung:
+65.19%
1-Tages-Spanne:
$4.37
$4.53
1-Wochen-Bereich:
$4.31
$4.64
52-Wochen-Spanne:
$1.33
$6.20
Neuraxis Inc Stock (NRXS) Company Profile
Firmenname
Neuraxis Inc
Sektor
Branche
Telefon
(812) 689-0791
Adresse
11550 North Meridian Street, Suite 325, Carmel
Vergleichen Sie NRXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
4.46 | 46.98M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuraxis Inc Aktie (NRXS) Neueste Nachrichten
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis - Nasdaq
Top Stock Reports for Meta, Bank of America & Procter & Gamble - Yahoo Finance
Aug PreEarnings: Can NeurAxis Inc stock double in next 5 years2025 Geopolitical Influence & Verified Trade Idea Suggestions - moha.gov.vn
Glenmark Will Innovation PayMarket Sentiment Indicators & Double Or Triple Capital - bollywoodhelpline.com
Neuraxis Inc. (NRXS) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Candlestick Reversal Detected on Universal Cables Limited’s ChartMarket Sentiment Shifts & Small Budget Wealth Tips - bollywoodhelpline.com
Portfolio Recap: Can NeurAxis Inc stock weather global recessionQuarterly Investment Review & Stepwise Trade Execution Plans - moha.gov.vn
NeurAxis (NASDAQ:NRXS) Director Gil Aharon Purchases 286,138 Shares - Defense World
NeurAxis Insider Makes Bold Multi-Million Move in the Market - TipRanks
Neuraxis Insider Bought Shares Worth $1,007,206, According to a Recent SEC Filing - marketscreener.com
Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN
Neuraxis achieves medical coverage policy milestone for PENFS - MSN
Craig-Hallum Maintains NeurAxis (NRXS) Buy Recommendation - Nasdaq
Aug Volume: Is NeurAxis Inc stock a safe haven assetM&A Rumor & Risk Controlled Daily Plans - moha.gov.vn
NRXS: Craig-Hallum Raises Price Target to $8.00, Maintains Buy R - GuruFocus
NeurAxis Expands VA Network and Secures Significant Coverage - timothysykes.com
Analyst Downgrade: What technical patterns form on Unith Ltd CM30 stock chartsWeekly Trade Analysis & Community Trade Idea Sharing Platform - moha.gov.vn
NeurAxis Expands Healthcare Reach with New VA and Insurance Agreements - StocksToTrade
NeurAxis Secures Major Health Insurance Coverages - timothysykes.com
How analysts rate NeurAxis Inc. stock todayFed Meeting & Free Weekly Watchlist of Top Performers - Улправда
Aug Macro: How NeurAxis Inc. stock reacts to global recession fears2025 Key Lessons & High Conviction Trade Alerts - Улправда
Can NeurAxis Inc. stock double in next 5 years2025 Market Trends & Step-by-Step Trade Execution Guides - Улправда
Will Neuraxis Inc. stock profit from fiscal stimulusWeekly Profit Analysis & Accurate Buy Signal Notifications - Улправда
Why NeurAxis Stock Climbed 15% - StocksToTrade
NeurAxis Stock Surges: Evaluating The Market Impact - timothysykes.com
Surprises Report: How analysts rate NeurAxis Inc. stock todayWeekly Profit Recap & High Conviction Investment Ideas - Улправда
Will Neuraxis Inc. stock outperform foreign stocksWeekly Gains Report & Daily Risk Controlled Trade Plans - DonanımHaber
NeurAxis Inc.’s New Path in VA: What This Means - timothysykes.com
NeurAxis Achieves Medical Coverage Policy Milestone, - GlobeNewswire
Will Neuraxis Inc. stock outperform energy sector in 2025Trade Performance Summary & Step-by-Step Trade Execution Guides - DonanımHaber
How NeurAxis Inc. stock reacts to global recession fearsTrade Volume Summary & Intraday High Probability Setup Alerts - Улправда
Earnings Risk: How higher bond yields impact Neuraxis Inc stockJuly 2025 Update & Capital Efficient Trading Techniques - moha.gov.vn
Breakout Move: Will Neuraxis Inc stock outperform energy sector in 2025Entry Point & Precise Trade Entry Recommendations - moha.gov.vn
NeurAxis, Inc. Earnings Call: Growth Amid Challenges - MSN
Is Neuraxis Inc. stock a defensive play amid uncertaintyJuly 2025 Gainers & Technical Entry and Exit Tips - Newser
Is Neuraxis Inc. stock good for wealth creationQuarterly Profit Review & Low Drawdown Investment Ideas - Newser
Chronic Constipation Market Set to Grow Substantially Through 2034, DelveInsight Projects - openPR.com
How supply shortages influence Neuraxis Inc. stock2025 Support & Resistance & High Yield Stock Recommendations - Newser
Is Neuraxis Inc. stock undervalued after correctionJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Neuraxis secures VA Federal Supply Schedule contract - MSN
What dividend safety rating applies to Neuraxis Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Dyadic International (DYAI) and NeurAxis, Inc. (NRXS) - The Globe and Mail
Neuraxis secures veterans affairs federal supply schedule contract, broadening access to more patients with functional abdominal pain - MarketScreener
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain - The Manila Times
NeurAxis Secures Veterans Affairs Federal Supply Schedule - GlobeNewswire
NeurAxis, Inc. (NRXS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
NeurAxis Expands Stock Offering to $6.27 Million - MSN
Finanzdaten der Neuraxis Inc-Aktie (NRXS)
Es liegen keine Finanzdaten für Neuraxis Inc (NRXS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
Kapitalisierung:
|
Volumen (24h):